J. Scott Wolchko, President and CEO at FATE THERAPEUTICS INC (FATE), sold 29,132 shares at $48.50 ($1.4M) on 2022-01-11, disclosed to the SEC on 2022-01-13.
Seasonal sale ($1.4M) by President and CEO — this insider has traded FATE in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $48.50 | 10,047 | $487K | 34.4% |
| 2 | $48.50 | 10,047 | $487K | 34.4% |
| 3 | $49.07 | 4,519 | $222K | 15.6% |
| 4 | $49.07 | 4,519 | $222K | 15.6% |
| Total | $48.68 avg | 29,132 | $1.4M | 100% |
| Filing → |
| FATE | SELL | 2022-07-25 | $2.4M | — | Filing → |
| FATE | SELL | 2022-04-25 | $2.6M | — | Filing → |
| FATE | SELL | 2022-01-24 | $2.0M | — | Filing → |